WeSearch
Hub / Tags / Melanoma
TAG · #MELANOMA

Melanoma coverage.

Every story in the WeSearch catalog tagged with #melanoma, chronological, with view counts. Subscribe to the per-tag RSS feed to follow this topic in your reader of choice.

10 stories tagged with #melanoma, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.

⌘ RSS feed for this tag →   or   search "Melanoma"

RELATED TAGS
#health1#cancer1#skin-cancer1#public-health1#healthcare1#dermatology1#eli-kasheri1#university-of-miami-miller-school-of-medicine1#journal-of-the-american-academy-of-dermatology1
INVESTING.COM — NEWS

Australia approves Iovance’s Amtagvi for advanced melanoma

16 views ·
NPR TOPICS: NEWS

A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.…

28 views ·
#health#cancer#immunotherapy
QUARTZ

Replimune is resubmitting its twice-rejected melanoma drug after FDA leadership exodus

15 views ·
MEDSCAPE

Earlier Melanoma Dx Seen in Regions With More Dermatologists

Higher dermatologist density is associated with lower proportions of late stage melanoma diagnosis across US health service areas, a study finds.…

16 views ·
#healthcare#dermatology
THE GUARDIAN — SCIENCE

Melanoma skin cancer cases in UK hit record level, analysis finds

Cancer Research UK figures show number diagnosed with most serious form of skin cancer has risen above 20,000 for first time…

18 views ·
#health#cancer
INVESTING.COM — NEWS

Iovance Biotherapeutics’ SWOT analysis: stock gains momentum on melanoma data

13 views ·
INVESTING.COM — NEWS

BMO cuts Regeneron stock price target on melanoma trial miss

16 views ·
YAHOO FINANCE

Regeneron Stock Sinks as Key Melanoma Drug Trial Fails to Beat Merck’s Keytruda

13 views ·
INVESTING.COM — NEWS

Regeneron shares fall 12% on disappointing melanoma trial data

20 views ·
INVESTING.COM — NEWS

BofA reiterates Regeneron stock rating after melanoma trial miss

14 views ·